BIBFRAME Work

Title

Hearing on examining policies that inhibit innovation and patient access

Type

• Text
• Monograph

Contribution

• United States. Congress. House. Committee on Ways and Means (author )

Subject

• Maladie d'Alzheimer--Traitement--Innovations--États-Unis (RVM)
• Centers for Medicare & Medicaid Services (U.S.)--Rules and practice. (LCSH)
• Pandémie de COVID-19, 2020- (RVM)
• United States. Food and Drug Administration--Rules and practice. (LCSH)
• COVID-19 Pandemic, 2020-2023 (LCSH)
• Science, Technology, Communications (CGPA)
• Alzheimer's disease--Treatment--Technological innovations--United States (LCSH)
• Medical innovations--Law and legislation--United States (LCSH)

Genre Form

• Legislative hearings (LCGFT)
• Audiences législatives (RVMGF)

Language

• eng

Illustrative Content

• illustrations

Classification

LCC: KF27 .W3 2023d (Assigner: dlc) (Status: uba)

Content

• text

Note

Hearing witnesses: Tony Gonzales, National Early-Stage Advisor, Alzheimer's Association; Ted Okon, Executive Director, Community Oncology Alliance; Dr. Darius Lakdawalla, Professor of Pharmaceutical Economics and Public Policy, USC Leonard D. Schaeffer Center for Health Policy & Economics; Dr. Joshua Makower, Director, Stanford Byers Center for Biodesign, Stanford University; Dr. Aaron S. Kesselheim MD, JD, MPH, Professor of Medicine, Harvard Medical School.

Supplementary content

• bibliography

Authorized Access Point

United States. Congress. House. Committee on Ways and Means. Hearing on examining policies that inhibit innovation and patient access

Government pub type

• federal or national

Capture

Date of hearing: 2023-05-10.

Geographic Coverage

• United States

Admin Metadata

• Date: 2026-09-11T20:12:03.106224+00:00
• Agent: cbc
• Status: c
• Derived from: 23700073

Admin Metadata

• Date: 2026-09-11
• Cataloger id: Unknown
• Description level: http://id.loc.gov/ontologies/bibframe-2-6-0/
• Description language: eng
• Description authentication: pcc